2020 Patient Care Network Virtual Summit

Thank you for attending the inaugural Patient Care Network Summit

Session presentations (when available) can be found below within each of the presenter's section.

• If you opted to earn CEs and CMEs, then you should have received an evaluation survey email. Please check your Junk or Spam folder.
• Contact us at pcn@hazeldenbettyford.org with any questions. 

Thursday and Friday, November 19-20, 2020

Register now for this information-packed, two-day Webex event. Participate in all of the virtual event, or come and go for sessions that are of interest to you. Details on how to log in will be provided to you upon registration. This is a complimentary event for Patient Care Network participants. Please share with your colleagues. CEs and CMEs are available; see details below. Contact us at PCN@HazeldenBettyFord.org with any questions.

Thursday, November 19, 2020 - 10 a.m.-4:30 p.m. CST
10-10:30 a.m.	Welcome and Opening Remarks Mark G. Mishek, President and CEO, Hazelden Betty Ford Foundation Mark Mishek Presentation
10:30-11 a.m.	Why Our Unity Is Our Strength: Championing a Collaboration-Powered Post COVID World Trey Malicoat, MS, Upsize Your Soul Center of Hope and Healing
11 a.m.-12:15 p.m.	Treatment of Opioid Use Disorder: From Clinical Care to Self-Management  Ahmed Eid, MA, LADC, Hazelden Betty Ford Foundation     1.25 CME and CE Available  Ahmed Eid Presentation
12:15-12:45 p.m.	Break and Virtual Networking Lunch
12:45-2 p.m.	No Wrong Door: Substance Use Disorders in Primary Care Jesse Higgins, MSN, RN, PMHNP, Northern Light Acadia Healthcare; Malia Holbeck, CSW-PIP, LAC, Avera Health  1.25 CME and CE Available No Wrong Door Presentation
2-3:15 p.m.	Embracing Telehealth as Part of Your Long-Term Strategic Plan Scott Palmer, MBA, and Jennifer Nelson, MA, LADC, Hazelden Betty Ford Foundation 1.25 CME and CE Available Jennifer Nelson Presentation
3:15-4:15 p.m.	Implementing Evidence-Based Practices into Behavioral Health and Medical Systems Randi Tolliver, PhD, CADC, Hazelden Betty Ford Foundation 1 CME and CE Available Randi Tolliver Presentation
4:15-4:30 p.m.	Wrap-Up
Friday, November 20, 2020 10 a.m.-4:15 p.m. CST
10-10:30 a.m.	Welcome Back to the Summit Patient Care Network Team: Jessica Wong and Ashley Thill
10:30-11:45 a.m.	Treatment Modifications and Outcomes for Online Versus In-Person Care Quyen Ngo, PhD; Kate Gliske, PhD;  and Samantha Pauley, MA, LMFT, Hazelden Betty Ford Foundation 1.25 CME and CE Available Telehealth Outcomes Presentation
11:45 a.m.-12:15 p.m.	Break and/or Lunch and Learn on Digital Products to Support Virtual Care Mark Korf, BA, Hazelden Publishing
12:15-1:30 p.m.	Substance Use Disorders and Psychiatric Comorbidities: Best Practices for Co-Occurring Disorders Azfar Malik, MD, MBA, DFAPA, President and CMO, CenterPointe Behavioral Health System 1.25 CME and CE Available
1:30-2:45 p.m.	Treatment Planning with ASAM Levels of Care Patrick McGinn, MA, MS, LLP, CAADC, CEO, Harbor Hall, Inc.; Peter Bucci, MA, LPC, ACS, CAADC, CSS, JSOTS, Harbor Hall Inc. 1.25 CME and CE Available Harbor Hall Presentation
2:45-3:45 p.m.	Panel Discussion: The Future of Behavioral Health A Roundtable with Mark G. Mishek and Executive Leadership of the Hazelden Betty Ford Foundation Moderated by William C. Moyers and featuring Marvin D. Seppala, MD; Quyen Ngo, PhD; Joseph A. Jaksha; Joseph Lee, MD; John Driscoll, MBA; Bob Poznanovich and Nick Motu
3:45-4:15 p.m.	Wrap-Up

---

About the Presentations

Treatment of Opioid Use Disorder: From Clinical Care to Self-Management

Examine the implications of medication-assisted treatment for opioid use disorder, including how bias and stigma prevent patients from seeking treatment and receiving medications for their condition. Learn about the need for a continuum of services to effectively meet the needs of patients struggling with this chronic disease. Consider specific challenges involved in treating patients with opioid use disorder in the midst of the COVID-19 pandemic.

Learning Objectives

• Recognize the unique circumstances and challenges in treating patients with opioid use disorder
• Define a model of care that fully addresses the chronic nature of the disease
• Explore how bias and stigma can thwart effective treatments

No Wrong Door: Substance Use Disorders in Primary Care

Learn about the integration of behavioral health care within a medical setting through an overview of two successful approaches: Northern Light Health’s Integrated Behavioral Health multi-hospital system model in Maine and Avera McKennan Healthcare System’s experience implementing Project ECHO in South Dakota and surrounding states. Northern Light Health leverages SBIRT (screening, brief intervention, and referral to treatment) in medical practices to successfully identify, treat and refer patients with substance use disorders while ProjectECHO connects providers together to share knowledge of mental health and addiction across the vast geographical areas Avera serves.

Learning Objectives

• Recognize the importance of addressing trauma and mental illness in assessing and treating substance use disorder
• Examine ways to leverage integrated clinicians within primary care in order to increase the confidence of medical practitioners in welcoming patients with substance use disorders into their practice
• Identify strategies and tools to promote inclusive, compassionate and empathetic care for each other and our patients

Embracing Telehealth as Part of Your Long-term Strategic Plan

Research from leading management consulting firm McKinsey indicates that consumer and organizational adoption of digital tools vaulted ahead five years over the course of just eight weeks following the emergence of COVID-19. This unprecedented acceleration ushered in a new era of widespread virtual care but left many organizations feeling underprepared for the transition. Learn how your organization can develop a holistic framework for thinking about virtual care and operationalize best practices for the benefit of your patients.

Learning Objectives

• Become more familiar with virtual platforms and ways to keep all parties engaged
• Identify etiquette considerations in the virtual world
• Determine best practices for ensuring confidentiality in a virtual setting
• Address challenges related to continuity and evidence-based care

Implementing Evidence-Based Practices into Behavioral Health and Medical Systems 

Investigate key components for implementation of evidence-based practices into existing systems of care. Learn how to gauge organizational readiness for implementation including practical strategies to address the needs and interests of personnel throughout the organization (e.g., executive leadership, directors, direct service providers, peer support professionals).

Learning Objectives

• Gauge your organization’s readiness to make changes
• Identify at least three strategies for increasing the adoption of evidence-based practices
• Determine next steps for your organization’s change efforts related to integration of behavioral health into medical services

Treatment Modifications and Outcomes for Online versus In-Person Care

What are the program characteristics needed to successfully launch virtual addiction care? The arrival of the COVID-19 pandemic hastened this transition for many addiction treatment centers, including Hazelden Betty Ford. Learn about the implementation science used to guide this transition at Hazelden Betty Ford and how the clinical treatment model was modified to enhance best practices needed to provide quality virtual services. Review the research process involved in this program evaluation and how Hazelden Betty Ford has come to understand treatment delivered virtually versus in-person.

Learning Objectives

• Define an implementation science framework to guide the transition into virtual treatment services
• Demonstrate insight, skill and advanced knowledge on how to implement, enhance and evaluate virtual services
• Recognize how to improve outcomes across virtual delivery formats

Lunch and Learn Topic: Digital Products to Support Virtual Care

See a preview of Hazelden Publishing’s new platform for dissemination of evidence-based materials and curricula to help organizations ensure continuity of care and achieve outcomes. Content includes Living in Balance and My Online Recovery Experience (MORE) as well as 200+ videos/facilitator guides, 150 articles and 100+ patient pamphlets. The platform is designed for digital content access anywhere, at any time and is customized to meet the individual patient’s needs.

Substance Use Disorders and Psychiatric Comorbidities: Best Practices for Co-Occurring Disorders

Psychiatric illness is common among patients who have a substance use disorder. With co-occurring disorders, both the mental health condition and the alcohol/drug addiction have their own unique symptoms.  To further complicate the situation, the co-occurring disorders also affect each other.  Review the psychiatric conditions most common among individuals with substance use disorders and examine programmatic approaches to treat both addiction and mental health issues.

Learning Objectives

• Identify diagnostic indicators of mood disorders in patients with substance use disorder
• Recognize potential treatments
• Discuss new and innovative treatments for various co-occurring disorders

Treatment Planning with ASAM Levels of Care

Gain a practical understanding of how to apply American Society of Addiction Medicine (ASAM) criteria in a treatment setting. More specifically, learn how providers can utilize the full extent of ASAM Dimensions and Levels of Care to deliver the quality care desired for the individual patient while meeting industry standards.

Learning Objectives

• Identify ASAM Dimensions and Levels of Care
• Integrate treatment planning to effectively address the Dimensions and Levels of Care
• Determine the full spectrum of treatment services based on the patient's needs

Learn about the Presenters

---

CEs and CMEs Available

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Medical Association of Georgia through the joint providership of Southern Alliance for Physician Specialties CME and Hazelden Betty Ford Foundation. The Southern Alliance for Physician Specialties CME is accredited by the Medical Association of Georgia to provide continuing medical education for physicians.

The Southern Alliance for Physician Specialties CME designates this live activity for a maximum of 8.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The Hazelden Betty Ford Graduate School of Addiction Studies is approved to provide Continuing Education Credits. The Graduate School is approved by the American Psychological Association to sponsor continuing education for psychologists. The Graduate School maintains responsibility for this program and its contents. The Graduate School is an NBCC approved Continuing Education Provider, ACEP # 6547, and may offer NBCC-approved clock hours for events that meet NBCC requirements. The ACEP solely is responsible for all aspects of the program. This course has been approved by Hazelden Betty Ford Graduate School of Addiction Studies, as a NAADAC Approved Education Provider, for educational credits, NAADAC Provider #77968. Hazelden Betty Ford Graduate School of Addiction Studies is responsible for all aspects of its programming. The Graduate School is approved to provide continuing education by Florida Certification Board # 5058-A, CAADE Provider # CP20 975 C 0322, CCAPP Provider Number 1N-88-160-1121 CADTP provider # 125, and CA BRN CEP 16722. Participants are required to keep their certificate for a minimum of six years. For information about this continuing education program, please contact the Hazelden Betty Ford Graduate School of Addiction Studies, P.O. Box 11 CO9, Center City, Minnesota 55012, 1-651-213-4538.